Xenetic Biosciences Inc (XBIO)
US$ 2.894.33%
Price Chart
Key Statistics
Market Cap
$ 4.72M
P/E Ratio
0.00
Revenue (TTM)
$ 2.58M
Volume
2.76K
52W High
$ 5.20
52W Low
$ 2.20
Dividend Yield
0.00%
Beta
2.32
Technicals
50-Day MA
2.9579
200-Day MA
3.7372
52 Week High
5.2
52 Week Low
2.2
About XBIO
Xenetic Biosciences, Inc., a biopharmaceutical company, focuses on advancing immune-oncology technologies to treat cancers.
Employees
2
Headquarters
Framingham, MA
CEO
Mr. James F. Parslow
Latest News
Xenetic Biosciences First Quarter 2025 Earnings: EPS Beats Expectations, Revenues Lag - simplywall.st
16 hours ago • Google News
Xenetic (XBIO) Reports Strong Revenue Growth for Q1 | XBIO Stock News - GuruFocus
2 days ago • Google News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg